24 results
Treatment Algorithm for First Time Pulmonary Embolism
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke,
Treatment Algorithm ... for First Time Pulmonary ... #PE #Pulmonary # ... Embolism #Treatment ... #Algorithm #management
Acute Pulmonary Embolism - Management Algorithms
 - Hemodynamically Stable Patients
 - Hemodynamically Unstable Patients

- Dr. Eric
Acute Pulmonary ... Embolism - Management ... Algorithms - ... Hemodynamically Stable ... #Algorithm #treatment
HESTIA Criteria for Outpatient Pulmonary Embolism Treatment - Identifies low-risk PE patients safe for outpatient treatment
HESTIA Criteria ... for Outpatient Pulmonary ... Embolism Treatment ... #Diagnosis #Management ... #HESTIA #Criteria
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
Asthma (GINA) treatment ... immunotherapy; FEV1: forced ... #GINA #Asthma #Management ... #Stepwise #Pulmonary ... #Algorithm #Guidelines
Pulmonary Embolism - Risk Stratification and Prognostication based on scores and clinical features

 • Bova score
Pulmonary Embolism ... score (30-day PE-related ... class (30-day all cause ... Hemodynamics (Stable ... prognostication #diagnosis #management
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... indicate preferred treatment ... corticosteroid; FEV1: forced ... #Management #Pulmonary
Treatment of Stable Narrow-Complex Tachycardia
Regular Rhythm:
 • Attempt vagal maneuvers
 • Give adenosine 6 milligrams IV
Treatment of Stable ... Treat underlying cause ... Treat underlying cause ... #management #cardiology ... #algorithm
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Algorithm for Chronic ... Obstructive Pulmonary ... assessment test; FEV1, forced ... #Algorithm #Management ... #Pulmonary #LABA
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
without other cause ... : 33% • Treatment ... , and CXR with pulmonary ... : No • Treatment ... diagnosis #comparison #table
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... for the treatment ... vein thrombosis; PE ... = pulmonary embolism ... Anticoagulation #Management
►